Razagilin Belupo 1 mg tablete
| Name | Razagilin Belupo 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-844440776 |
| Active Substance | razagilin hemitartarat |
| Composition | svaka tableta sadrži 1 mg razagilina (u obliku hemitartarata) |
| Pharmaceutical Form | tableta |
| Manufacturer | Genepharm S.A., Pallini Attiki, Grčka Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 22.04.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/12 |
| Registration Number | 381-12-01/70-22-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BD02 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
